LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Income from Continuing Operations
LBX Pharmacy Chain JSC
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Income from Continuing Operations
¥363.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Income from Continuing Operations
¥1.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Income from Continuing Operations
¥140m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Income from Continuing Operations
¥563.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Income from Continuing Operations?
Income from Continuing Operations
1.2B
CNY
Based on the financial report for Mar 31, 2024, LBX Pharmacy Chain JSC's Income from Continuing Operations amounts to 1.2B CNY.
What is LBX Pharmacy Chain JSC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
17%
Over the last year, the Income from Continuing Operations growth was 10%. The average annual Income from Continuing Operations growth rates for LBX Pharmacy Chain JSC have been 13% over the past three years , 17% over the past five years .